Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Allergy and Immunology (1)
- Community Health and Preventive Medicine (1)
- Health Services Research (1)
- Health and Medical Administration (1)
- Hemic and Lymphatic Diseases (1)
-
- Infectious Disease (1)
- Life Sciences (1)
- Medical Immunology (1)
- Medical Sciences (1)
- Medical Specialties (1)
- Mental and Social Health (1)
- Oncology (1)
- Patient Safety (1)
- Pharmacology (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Public Health (1)
- Substance Abuse and Addiction (1)
- Virus Diseases (1)
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Hemic and Immune Systems
Covid-19 Vaccination And Alcohol Consumption: Justification Of Risks, Pavel A. Solopov
Covid-19 Vaccination And Alcohol Consumption: Justification Of Risks, Pavel A. Solopov
Bioelectrics Publications
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, pharmaceutical companies and research institutions have been actively working to develop vaccines, and the mass roll-out of vaccinations against COVID-19 began in January 2021. At the same time, during lockdowns, the consumption of alcoholic beverages increased. During the peak of vaccination, consumption remained at high levels around the world, despite the gradual relaxation of quarantine restrictions. Two of the popular queries on search engines were whether it is safe to drink alcohol after vaccination and whether this will affect the effectiveness of vaccines. Over the past two …
Real-World Third Covid-19 Vaccine Dosing And Antibody Response In Patients With Hematologic Malignancies, Michael A. Thompson, Sigrun Hallmeyer, Veronica E. Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, James L. Weese
Real-World Third Covid-19 Vaccine Dosing And Antibody Response In Patients With Hematologic Malignancies, Michael A. Thompson, Sigrun Hallmeyer, Veronica E. Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, James L. Weese
Journal of Patient-Centered Research and Reviews
Purpose: This study sought to describe the changes in immune response to a third dose of either Pfizer’s or Moderna’s COVID-19 mRNA vaccine (3V) among patients with hematologic malignancies, as well as associated characteristics
Methods: This retrospective cohort study analyzed pre-3V and post-3V data on 493 patients diagnosed with hematologic malignancies across a large Midwestern health system between August 28, 2021, and November 1, 2021. For antibody testing, S1 spike antigen of the SARS-CoV-2 virus titer was used to determine serostatus.
Results: Among 493 participants, 274 (55.6%) were seropositive both pre- and post-3V (+/+) while 115 (23.3%) seroconverted to positive …